The Johns Hopkins University Patent Portfolio Statistics

The Johns Hopkins University

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of The Johns Hopkins University look like?

Total Applications: 2,866
Granted Patents: 1,547
Grant Index 64.73 %
Abandoned/Rejected Applications: 843 (35.27%)
In-Process Applications: 469
Average Grant Time: 3.09 Years
Average Office Actions: 1.95

Which Technology Area The Johns Hopkins University is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1634 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 132
Opap Parked GAU 126
1642 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 97
1618 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs 87
1644 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 71

How many patents are The Johns Hopkins University filing every year?

Year Total Applications
2022 0*
2021 106*
2020 147
2019 178
2018 206

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of The Johns Hopkins University in USPTO?

Publication number: 2022015934
Application number: PCT/US21/41754

Abstract:
None

Publication date: 2022-01-20
Applicant: The Johns Hopkins University
Inventors: B Harry Larman


Publication number: US20210078685A1
Application number: 17/012,340

Abstract:
A modular compartment bulkhead assembly is provided that includes a first external body, a bulkhead, and a second external body. The first external body segment may include a first end portion. The first end portion may be coupled to an external seal body and the external seal body may include a first internal channel. The bulkhead may include an internal seal body. The internal seal body may be configured to be inserted into the first internal channel of the external seal body to form an internal seal between the bulkhead and the first external body segment. The second external body segment may include a second end portion. The second end portion may include a second internal channel, and the external seal body may be configured to be inserted into the second internal channel to form an external seal between the external seal body and the second external body segment.

Publication date: 2021-03-18
Applicant: The Johns Hopkins University
Inventors: Brendan Mcnelly P


Publication number: US20200109124A1
Application number: 16/704,137

Abstract:
Compositions and methods for visualizing tissue under illumination with near-infrared radiation, including compounds comprising near-infrared, closed chain, sulfo-cyanine dyes and prostate specific membrane antigen ligands are disclosed.

Publication date: 2020-04-09
Applicant: The Johns Hopkins University
Inventors: Ray Sangeeta


How are The Johns Hopkins University’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
PCT/US21/41754 Comprehensive Analysis Of Anti-Allergen Antibodies Using Phage Display 3903 Thomas, Shane M
17/012,340 Modular System For Submersible Vehicle Docketed New Case – Ready for Examination 3617 Wiest, Anthony D
16/704,137 Psma Targeted Fluorescent Agents For Image Guided Surgery Abandoned — Failure to Respond to an Office Action 1618 Perreira, Melissa Jean
62/937,708 Intranasal Leptin Prevents Opioid-Induced Respiratory Depression In Obesity
16/475,805 Development Of New Monoclonal Antibodies Recognizing Human Prostate-Specific Membrane Antigen (Psma) Non Final Action Mailed 1643 Rawlings, Stephen L